These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 2217518)

  • 1. Sensitization versus tolerance to haloperidol-induced catalepsy: multiple determinants.
    Barnes DE; Robinson B; Csernansky JG; Bellows EP
    Pharmacol Biochem Behav; 1990 Aug; 36(4):883-7. PubMed ID: 2217518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haloperidol conditioned catalepsy in rats: a possible role for D1-like receptors.
    Banasikowski TJ; Beninger RJ
    Int J Neuropsychopharmacol; 2012 Nov; 15(10):1525-34. PubMed ID: 22093169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of age and isolation on the evolution of catalepsy during chronic haloperidol treatment.
    Frussa-Filho R; Otoboni JR; Uema FT; Palermo-Neto J
    Braz J Med Biol Res; 1992; 25(9):925-8. PubMed ID: 1342840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential tolerance to cataleptic effects of SCH 23390 and haloperidol after repeated administration.
    Lappalainen J; Hietala J; Syvälahti E
    Psychopharmacology (Berl); 1989; 98(4):472-5. PubMed ID: 2570432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated testing of rats markedly enhances the duration of effects induced by haloperidol on treadmill locomotion, catalepsy, and a conditioned avoidance response.
    Hillegaart V; Ahlenius S; Magnusson O; Fowler CJ
    Pharmacol Biochem Behav; 1987 May; 27(1):159-64. PubMed ID: 3615537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance of haloperidol catalepsy.
    Ezrin-Waters C; Seeman P
    Eur J Pharmacol; 1977 Feb; 41(3):321-7. PubMed ID: 556989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase of spiny I activity in striatum after development of context-dependent sensitization of catalepsy in rats.
    Frank ST; Schmidt WJ
    Neurosci Lett; 2004 Jan; 354(1):10-3. PubMed ID: 14698470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditioned tolerance to haloperidol- and droperidol-induced catalepsy.
    Nowak K; Welsch-Kunze S; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Apr; 337(4):385-91. PubMed ID: 3405313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of haloperidol conditioned catalepsy in rats by the dopamine D3 receptor antagonists nafadotride and NGB 2904.
    Banasikowski TJ; Beninger RJ
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):761-8. PubMed ID: 22410316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haloperidol-induced within-session response decrement patterns and catalepsy in rats: behavioural dissociation.
    Drinkenburg WH; Keith AB; Sahgal A; Andrews JS
    Behav Pharmacol; 1999 Feb; 10(1):105-11. PubMed ID: 10780307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of repeated testing on the incidence of haloperidol-induced catalepsy in mice.
    Iwata S; Izumi K; Shimizu T; Fukuda T
    Pharmacol Biochem Behav; 1989 Jul; 33(3):705-7. PubMed ID: 2587613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The characteristics of the minute fluctuations in haloperidol-induced catalepsy and the contribution of different sections of the striatum to their formation in rats].
    Arushanian EB; Popov AV; Popova AP
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(3):573-82. PubMed ID: 1323183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
    Agovic MS; Yablonsky-Alter E; Lidsky TI; Banerjee SP
    Eur J Pharmacol; 2008 Jun; 587(1-3):181-6. PubMed ID: 18457824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine potentiates the behavioral effects of haloperidol.
    Emerich DF; Norman AB; Sanberg PR
    Psychopharmacol Bull; 1991; 27(3):385-90. PubMed ID: 1775613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
    Zharkovskiĭ AM; Matvienko OA; Nurk AM
    Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperprolactinemia and catalepsy induced by haloperidol].
    Reggio A; Condorelli DF; De Simone D; Giammona G; Maccagnano C; Panico AM; Tigano G
    Boll Soc Ital Biol Sper; 1981 Aug; 57(16):1655-9. PubMed ID: 7197982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ontogeny of tolerance to haloperidol: behavioral and biochemical measures.
    Coyle S; Napier TC; Breese GR
    Brain Res; 1985 Nov; 355(1):27-38. PubMed ID: 4075104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine and muscarinic antagonists act in synergy to inhibit haloperidol-induced catalepsy.
    Moo-Puc RE; Góngora-Alfaro JL; Alvarez-Cervera FJ; Pineda JC; Arankowsky-Sandoval G; Heredia-López F
    Neuropharmacology; 2003 Sep; 45(4):493-503. PubMed ID: 12907310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosing time-dependent tolerance of catalepsy by repetitive administration of haloperidol in mice.
    Viyoch J; Ohdo S; Yukawa E; Higuchi S
    J Pharmacol Exp Ther; 2001 Sep; 298(3):964-9. PubMed ID: 11504791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalepsy induced by SCH 23390 in rats.
    Morelli M; Di Chiara G
    Eur J Pharmacol; 1985 Nov; 117(2):179-85. PubMed ID: 2866970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.